Copenhagen, Denmark – October 25, 2017 – Novozymes, the world’s largest industrial biotechnology company, today announced its results for the nine months of 2017. Solid results with 4% organic revenue growth (Q3: +8%): Household Care +2%, Food & Beverages +9%, Bioenergy +10%, Agriculture & Feed -2%, Technical & Pharma -3%. Reported EBIT margin at 27.9%. FCF bef. acq. DKK 2.1 billion.
Peder Holk Nielsen, President & CEO of Novozymes:
“We grew revenue by 8% organically in the third quarter and by a satisfying 4% in the first nine months.
This was better than expected.
The EBIT margin was solid, as was free cash flow.
And although there is still some uncertainty regarding the fourth quarter, especially within agriculture-related industries, we are adjusting the full-year outlook.
With stronger innovation and a well-diversified business showing good, solid momentum, we are positive looking ahead.”
Novozymes’ executive leadership team will present the results at a conference call today at 9:00 am CEST: https://novozymes.eventcdn.net/2017q3/
The entire earnings report can be downloaded at novozymes.com.